Delivery Order SPE2DB22D3016-SPE2DB24FAGJ0
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,322.28 to Amerisourcebergen Drug Corporation for the supply of 21 packages of Loestrin 21 1.5-30 tablets. Amerisourcebergen Drug Corporation will perform under the contract from its location in Conshohocken, Pennsylvania, fulfilling the requirements between June 30 and July 3, 2023. As a major supplier of pharmaceuticals and medical goods, Amerisourcebergen Drug Corporation is a division of Amerisourcebergen...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order valued at $2,308.87 from the Defense Logistics Agency (DLA) Troop Support Medical to supply LO LOESTRIN FE 1-10 TABLET 28S pharmaceutical products. Performance will occur at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania with completion by November 13, 2023. This order was awarded against an indefinite delivery contract held by Amerisourcebergen with no set-aside designation specified. As a leading...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $2,033.08 contract is for the delivery of LO LOESTRIN FE 1-10 TABLET 28S pharmaceuticals to support military treatment programs and facilities. Amerisourcebergen Drug Corp, as a prime contractor, has a history of providing pharmaceuticals, medical supplies, and distribution services to DLA under various...
- The Defense Logistics Agency awarded a $3,814.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 21 packages of Loestrin 21 1.5-30 tablets. Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by September 18, 2023 under the terms of the order. As a major distributor of pharmaceuticals and medical supplies, Amerisourcebergen Drug Corporation will support the Defense Logistics Agency's...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $2,174.60 firm fixed-price contract is for the supply of Loestrin 21 1.5-30 tablets, a prescription oral contraceptive. The order has an ultimate completion date of August 13, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $13,132.64 firm fixed-price contract is for the supply of Loestrin 21 1-20 tablets. The award has a completion date of March 7, 2023 and is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $3,333.72 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply 4563079834 LO LOESTRIN FE 1-10 TABLET 28S pharmaceutical products. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by December 13, 2023. No set-aside designation was applied to this award made to support DLA's provision of...
- The federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of Loestrin 21 1-20 tablets to the Department of Defense's Medical Supply Chain. The contract is a firm fixed price delivery order with a ceiling value of $9,214.60 and a performance period through March 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is not associated with a set-aside program. The company also holds an indefinite delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,790.10 by the Defense Logistics Agency's Medical Supply Chain on August 20, 2025, with an ultimate completion date of August 21, 2025. The contract, issued under firm fixed-price terms with no set-aside designation, covers the supply of Loestrin 21 1-20 tablets in a quantity of 21 units. This delivery order represents a child contract under...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $1,667.25 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 4562989900 LO LOESTRIN FE 1-10 TABLET 28S. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by December 6, 2023. No set-aside designation was applied to this award to supply pharmaceutical products in support of military treatment...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FAGJ0Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order, valued at $3,529.51, is for the delivery of Loestrin 21 1-20 tablets. This is a firm fixed price contract with no set-aside designation. Amerisourcebergen Drug Corp, through its corporate office, has received numerous federal contract awards from DLA to supply pharmaceuticals, medical supplies, and related distribution services in support of DLA Troop Support Medical programs. The place of performance is Amerisourcebergen's headquarters in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp also holds an indefinite delivery contract with the Department of Justice Federal Bureau of Investigation to provide medical supplies and prescription medications, with a potential value of $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 12/19/23 |